Frederic Davi Selected Research

Frederic Davi Research Topics

13	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022 - 01/2009
9	Neoplasms (Cancer) 01/2022 - 01/2002
4	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2021 - 01/2002
4	Lymphoma (Lymphomas) 01/2019 - 02/2012
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 06/2015 - 09/2011
1	Lymphocytosis 01/2021
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 10/2018
1	Meningitis 10/2018
1	Disease Progression 11/2014
1	Bacterial Infections (Bacterial Infection) 12/2013
1	B-Cell Lymphoma (Lymphoma, B Cell) 12/2013
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2013
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2012
1	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 02/2012
1	Infections 02/2012

10	Immunoglobulins (Immunoglobulin)IBA 11/2021 - 01/2009
7	AntigensIBA 01/2019 - 01/2009
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022 - 01/2021
2	Biological ProductsIBA 01/2022 - 02/2012
2	Complementarity Determining Regions (Complementarity Determining Region)IBA 01/2019 - 10/2012
2	Interleukin-10 (Interleukin 10)IBA 10/2018 - 11/2013
1	Immunoglobulin M (IgM)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	ParaffinIBA 01/2021
1	Formaldehyde (Formol)FDA Link 01/2021
1	Fluorescent Dyes (Fluorescent Probes)IBA 06/2019
1	InterleukinsIBA 10/2018
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2016
1	fludarabineIBA 02/2016
1	Rituximab (Mabthera)FDA Link 02/2016
1	Messenger RNA (mRNA)IBA 06/2015
1	Cytidine DeaminaseIBA 06/2015
1	Interleukin-10 ReceptorsIBA 11/2013
1	Terminator Codon (Termination Codon)IBA 10/2012
1	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 01/2009
1	Proteins (Proteins, Gene)FDA Link 04/2004